High C5a levels stimulate linfoma with decreased infiltration of CD4+ and CD8+ T cells, while low levels of C5a in the TME decrease tumor progression, thus, the local concentration of C5a, independent of complement activation, seem to be critical to determine its role in tumor progression (61). The gene discussed is C5; the disease is neoplasm.